CJC-1295 / Ipamorelin vs AOD-9604

An honest, side-by-side look at two treatment options — so you and your provider can decide what may work best for you.

How Do They Compare?

CJC-1295 / Ipamorelin (Growth hormone secretagogue combination) and AOD-9604 (Modified growth hormone fragment for body composition) are both options in the peptide treatment space. CJC-1295 / Ipamorelin CJC-1295 combined with Ipamorelin is a peptide combination that may stimulate natural growth hormone release to support body composition, recovery, and overall wellness. AOD-9604 AOD-9604 is a modified fragment of human growth hormone that is being studied for its potential role in supporting fat metabolism without the growth-promoting effects of full GH. Your provider can help determine which treatment, if any, may be appropriate based on your individual health profile and goals.

All medications referenced on this page are compounded by a licensed 503A pharmacy and are not FDA-approved.

Side-by-Side Comparison

CJC-1295 / Ipamorelin

Coming Soon
Coming Soon

Join the waitlist to be notified

Category

peptide

Description

Growth hormone secretagogue combination

Features

  • Combination peptide approach
  • May support growth hormone release
  • May improve sleep and recovery
  • Administered via subcutaneous injection

Considerations

  • Compounded medications are not FDA-approved
  • Side effects may include water retention and tingling
  • Requires ongoing lab monitoring
  • Individual results vary

AOD-9604

Coming Soon
Coming Soon

Join the waitlist to be notified

Category

peptide

Description

Modified growth hormone fragment for body composition

Features

  • Modified fragment of growth hormone
  • May support fat metabolism
  • Does not affect blood sugar or growth
  • Administered via subcutaneous injection

Considerations

  • Not FDA-approved
  • Research is still emerging
  • Side effects not fully characterized
  • Requires provider supervision

Frequently Asked Questions

Be the First to Know

One or more treatments on this page are coming soon. Join our waitlist to be notified when they become available, if prescribed by a provider.

Join the Waitlist

Dive Deeper

Compounded tirzepatide is not FDA-approved. All treatments require evaluation and prescription by a licensed healthcare provider. Individual results may vary. This information is not intended to diagnose, treat, cure, or prevent any disease.

Ready to Explore Your Options?

Connect with a licensed provider who can help determine which treatment may be appropriate for your individual health goals.

Get Started

Ready to get started?

Talk to a licensed provider

Get Started